ABSSSI Therapeutic Market

Apr 23, 2021

The introduction of antibiotics subsequently transformed the healthcare industry bringing on the table several life-saving drugs. Long 60 years back, when the first antibiotic, Penicillin, came into existence, a new era of medicine with the potential to cope up with bacterial infections began.  However, the...

Mar 16, 2021

Merck, Gilead  to co-develop combined HIV treatments Merck and Gilead have announced a collaboration to investigate Gilead’s investigational capsid inhibitor, lenacapavir, and Merck’s investigational nucleoside reverse transcriptase translocation inhibitor, islatravir, into a two-drug regimen.  Both...

May 08, 2019

Our previous article discussed the overlay of Skin Structure Infections and available therapies. In this article, we will focus more on the treatment modalities and the emerging pipeline, which is sure to metamorphose the therapy area of Skin structure infections. As per the statistics of DelveInsight, Acute Bacter...

May 06, 2019

A skin and skin structure infection (SSSI), also referred to as acute bacterial skin and skin structure infection (ABSSSI) or skin and soft tissue infection (SSTI), is a bacterial infection of the skin and associated soft tissues. These are the common infections of epidermis, dermis, loose connective tissue, mucous...